Cointime

CureGenetics

company

About

Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.

  • 51 - 100

Highlights

Total Funding Amount
$17M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$17M
Industries
Biotechnology,Genetics,Health Care
Founded date
Jan 1, 2016
Number Of Employee
51 - 100
Operating Status
Active

Cure Genetics is a biotechnology company developing cutting-edge applications of technologies in innovative medicines and molecular diagnostics for the next-generation treatment of cancers and genetic diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$17M
CureGenetics has raised a total of $17M in funding over 2 rounds. Their latest funding was raised on Aug 6, 2018 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 6, 2018 Series A $17M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
CureGenetics is funded by 1 investors. Ascendin Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Ascendin Fund — Series A
Cointime
เนื้อหา
บริษัท